The "Squawk on the Street" news team weighs in on leadership changes at Procter & Gamble, and whether the company lost its "mojo."» Read More
The recent market turmoil is causing many investors worry, but not every sector is plagued by nervousness. Some sectors seem to be immune to the turmoil and others, like healthcare, seem to be thriving.
The economic slowdown may be causing some consumers to forfeit dining out or to “trade down” and eat at fast-food restaurants. Burger King CEO John Chidsey says his company is benefiting from this trend.
Sprint Nextel said Thursday Chief Financial Officer Paul Saleh and two other top executives would leave the company in a new management shake-up as the No. 3 U.S. mobile service grapples with subscriber declines.
As I stand outside. Ford headquarters on a brutally cold day, I'm toying with how to make a play on words about Ford's 4Q earnings might be warming the hearts and portfolio's of it's investors.
This press release and letters to the CEOs of MRK and SGP from the House Energy and Commerce Committee just arrived in my inbox:
Bank of America's CEO says he is not pleased with his own company's performance and sees anemic growth for 2008. Still, he believes the purchase of Countrywide will close in the second half of this year, sending CFC shares up in early trading.
Give the guys at the blue oval credit. Their new model and new technology push is getting the attention of younger buyers. I'm not ready to say Ford's line-up is packed with models the youngsters want, but there's definitely momentum building.
After watching his stock lose more than one-fifth of its value this week, Schering-Plough CEO Fred Hassan apparently decided the shares are on sale. This morning the company issued a press release announcing Hassan (pronounced Haa-sun, not the commonly mispronounced Huh-sahn) will shell out $2 million of his own money to buy SGP shares on the open market.
Next Tuesday, the University of San Diego’s Burnham-Moores Center for Real Estate is holding its 12th annual real estate conference. The keynote speaker: Angelo Mozilo, co-founder and CEO of Countrywide. That drew the ire of locals who formed “Disinvite Mozilo.”
In a form filed after the bell with the SEC, Countrywide says its board has decided to award "retention grants" to all executive officers except CEO Angelo Mozilo.
This afternoon, GM investors got the kind of good news they've been craving for several months. Talking with analysts in Dearborn, Michigan, GM's Chairman and CEO Rick Wagoner said the company plans to save an additional $5 billion by 2011.
I heard a new term the other day. You're probably familiar with it, but it was new to me: Hot Money. It's a reflection of the new kind of market dynamics we're all seeing lately, and the best, fresh example of "hot money" is Advanced Micro Devices.
If or when you watch one of the presidential debates count how many times the candidates say, "the drug companies." Of course, it depends on which party's debate you might be watching, but since I started paying attention to the race in recent weeks, I've taken notice how much those three words seem to be apart of boilerplate answers and statements...
When it comes to Countrywide CEO Angelo Mozilo and his potential multi-million dollar severance package, you people don't hold back.
The former chief executive of Brocade Communications Systems was sentenced to 21 months in prison for orchestrating a scheme to tamper with the company's records of stock option grants.
This is the text of my live blog from the Steve Jobs speech at Macworld. It was fun to do and I hope you enjoy reading it for the first time, or re-reading it again.
The new CEO's made some moves, but not enough.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
I had planned to blog about the nearly unanimous bearish analyst commentary this morning after Genentech's earnings report yesterday. The biotech giant beat on earnings per share, but came up short on Street expectations for sales of its top four drugs. DNA shares are under pressure again today.
In the wake of Pfizer pulling the plug on its poor-selling inhaled insulin Exubera, the world's biggest diabetes drug company, Novo Nordisk is throwing in the towel on development of its version of inhaled insulin.
A Congressional committee said on Monday it invited current and former chief executives of three major financial institutions -- Countrywide Financial Corp , Citigroup and Merrill Lynch -- to testify on Feb. 7 about their severance packages.